Charlty Reslstratlon Na. 115m9
Hisnocyrosis UK
KNOWN A5
HISTIO UK
ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS
FOR ThE YEAR ENDED 31 MARCH 2024

HISTiocYfosis UK
Hisfio UK
LEGAL AND ADMINISTRAnvE INFORMATION
Truste41
MrA Kontoyannls, Chalr
Prof. P Beverlev
Drv Nandurl
Mr P Blenenstock
Prof. M Collln
Prnf. C 800th
Dr R Tattersall
Othff oft•rs
Lynn Jackson, Exrcutlve Dlrector
Ch•rfty numb•r
1158789
Prfndpal addrnm
PO Box 159
Llsknard
Cornwall
PL14 9DQ
Indwnd•nt •Mmln•r
TC Group
33 805ton Road
Holbeach
Spaldlng
Llncolnshlre
PE12 7LR
BAnk•
CAF Bank Llmtted
25 KlnB5 Hlll Avenue
Kln8s Hlll West Mallln8
Kent
ME19 4JQ

HisllocYT051S UK
HISTIO UK
Trustees, report
Statement of trustees, responslblllttes
Independent examlner's report
Statement of flnanclal acrfvftles
Bilance Sheet
10
Notes to the flnanclal statements
11.18

HISTiocYfosis UK
Hisllo UK
TrUSTEES' REPORT
FOR ThE YEAR ENDED 31 MARCH 2024
The trustees present thelr report and flnanclal statements for the year ended 31 March 20
ObJe¢tlveJ and actlvltlei
Publk benefft
The object of the CIO Is the rellef of slckne55 Jnd preservatlon of good health arnon8 patferts affected by
hlstloLVtlc dlseases thelr famllles and carers, In partlcular but not exclu51vely ty:
(l) the promotlon and furtherance of sclentlflc research Into the physloloBy and patholo8y of hI￿OLytes and
the aetlolo8y of hlstlocytocytlc dlseases, the useful results of whlch wlll be dlssemlnated for the publk benefft;
(11) the development of more accurate means of dlagnosls, Improved protocols for mana8ement of patlents
and uhlmately measures for preventlon of hlstlocytlc dlseases.
(111) the provlslon and dlssemlnatlon of Inforni•tfon, educatlon and kn(wledse In 5UPPQrt of ydents Ind
famllles affected by the dlsease to Include the medlcal professlons and 8eneral publlc:
(Iv) collaboratlon wlth Interested Indfvlduals and or8anlsatlons.
The Trustees conflrm that they have referred to the 8uldance contalned In the Charlty Comrnlsslon's 8eneral
guklance on publ1¢ benefft when revlewln8 the Charttls alms and objecdves and In plannlng future actlvltles
and settln8 the grant makln8 pollcy for the year.
The Charlty carrles out these objectlves by focusln8 on these areas through whlch we achleve our strate8lc
prlorltles of malntalnlng a stsble pro8rnmme and the contlnued fundln8 of vltal research. The beneffts of the
Charft￿S work are the development of future research, the dIs￿mInatIon of research Ilndln8S, the
development of new theraples and the fundln8 of on-golng research wlth the 8oal belng able to Infomi
sufferers, thelr carers and famllles.
The trustees confirni that they ha￿ complled wlth the requlrements of section 17 of the CharltlesAct 2011 to
have due regard to the publlc benefft 8uld8nce publlshed by the Charlty Commtsslon for England and Wales.
Flnandil Report
Investmentpollry and oblectlves
The CharltVs pollcy at present Is to Invest In Iow-rlsk and reasonably Ilquld assets, so that funds are avallable to
meet any unforeseen needs that may arlse. for exarnple, as a consequence of meetlng actlvltles.
As far as posslble, the Charlty seeks to follow an ethkal Investment strJte8Y that precludes Inv&ttn8 In any
company whose activltle5 may ha￿ an adverse lrnpart on the underlyln8 beneficlarle5 of the charlty. Whlle
strlvlng for the hlghest ethlcal stsndards. the Charlty wlll adhere to the Charlty Commlsslon's rule that we
maxlmlse the Income of the charlty wlthout exposure to undue rtsk.

Hisnocyrosis UK
HISTIO UK
TrUSTEES' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MAR012024
Flnandal revlew
The Chalrrnan re8ul8rly revlews the reserves of the charlty to ensure that sufflclent Ilquld funds are avallable to
the Charlty to meet Its on8oln8 obllEatlon$. The reserves throu8hout the accountln8 perlod have been
adequate to fujftl thls objectlve.
Inmme a Expendfture Summary
The 2023-2024 Income was Steady agalnst the prevlous flnanclal yejr. Charltle5 In general sufferln8 from the
contlnued downturn In the cost of Ilvlng raTsln8 concerns In the 'cost of 81vIn￿ In thls econornlc dlmth.
We thank all of our generous donor5, the Indlvlduals, cornmurllty 8roups, schools, corporate supporters.
Charltles and Foundatlons that contlnued thelr support and refiect5 the excellent partlclpatlon, drhe and
8enerosOty of our communtty fundralser5, SUPPOrters, famllles and committed Indlvlduals that have bfftn able
to asslst us malntaln the Charlty.
6rnntAwar
In 2023 Hlstlo UK placed a call for Researth Paper5, eleven appllcatlons were recelved. After sub5tantlal revlew
by the Sclentlflc Revlew Board and conflrmatlon of the Board of Trustees In February 2024 an award dfer was
mode to: Tatlana von Bahr Greenwood,. MD, PhD and her tsam for a project to Establlsh a European CNSLCH
Ré8lstry In the sum of £50,CIJO made In February 2024.
Gronts Recelved
Nll In the flnanGl•l year
Chalrmin'i St•t•M•nt
Flnonclal
Thls year contlnues to place a strnln on our Charlty Income, In118ht of thls we have adjusted ourpractlses and
bud8ets.
Refiectlng on thls past year of operatlon we are 8rateful for the amazlng support that we have recelved, both In
funds and the tlme and energy of our amazln8 volunteers and Hlstlo Champlons. We contlnue to recognlse that
the current economk dlmate effects not only us, but all of our Hlstlo Communlty and beyond remalnln8 a very
dlfflcult perlod for all.
De5pFte reduced Income we have been able to contlnue our Inforniatlon Support servkes and Partnershlp
Project5.
We are very pleased to have contlnued and further developed our varlous Hlsttocytlc Informatlon 8uldes and
soclil medla plattorms allowln8 US to engage further wlth our Patlents, Parents and Supporter5.
In assoclat5on wlth our partners, we wlll contlnue to support hlstlocytlc profe551onals, patlents and famllle5 wlth
up-ttrdate Informatfon on these devastatln8 dlsorders as It becomes avallable.
Thankyou all.

HisfiocYTOSIS UK
HISTIO UK
TRUSTEES, REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
Partn•rshlps
H141AfG Haemophagocyrfc Lynyhohlsrfocytwb IHUIJAcross Spedallty Collaboradon
Hlstlo UK provldes webslte admlnlstratlve support to th15 amazln8 8roup.
Hlstlo UK provldes webslte admlnlstratlon to thls establlshed r4lstry program.
PPPIE Panel-Paden¢ Paren¢ Publk In￿ement a Enqaoement Panel
Hlstlocytosls UK Is commltted to me•nln8ful patlent and publlc Involvement and publlc en8a8ement fi)r and on
behalf of not onty tts own Grant Fund Awards but to apprn15e those of other Researchers and or Orgartsatlons
In the fleld af research wlth prlorlty to those of Hlstfocytlc dlseases.
Our vhlon wlth M8ards to patlenL parent and publlc Involvement and en8a8ement Is-
"to establlsh a culture wTrthln Hlstlocyt0515 UK where our communlty has the skllls and resources t opJmlse
and dellver patlent and publlc Involvement and en8a8ement and It15 Inte8rated In to our ways of worklng and
throughout the research we fund and appralse.
Hlstlocytosls UK his, In consultatlon wlth researcher6, publlc contrlbutors and Invofvement professlonals,
Identffied 6 Jlm5 that wlll 8ulde Hlstlocytosls UK and Its en8a8ement programme to work towards It's vlslon
that No one should dle of H15tlocytOs1s:
Ensure our research communlty Incorporates patfent and publlc Involvernent and engagement
throughout research.
Incorporate relevant Involvement throu8hout our fundlré processes.
Lead by example In our Involvement and enp8ernent practlce.
Strengthen Involvement and engagement practlce of Hlstlo UK'S PJtlenL Parent & Publlc Involvement
Enga8ement Panel.
Insplre and encournge Incluslve, Innovatlve, dlver5e and creatfve patlent, parent and publlc
Involvement and engagement.
Improve the knowled8e 5harln8 of patlent, parent and publlc Involvement and ew8ement.
The Hlstlocyt• Socl•ty
The HS Is the or8anlsatlon representln8 cllnlcal and research profe551onals In the field of Hlstlocyttc dlsorders.
They have agreed to share thelr vlrtual educatlonal programme wlth us durlng the 2023-2024 perlod.
The Nlkol•J Symposlum
Offerln8 the opportunlty to showcase new Ideas, facllltate asplratlonal thlnklng, and develop Inn￿atIve
research.

Hisriocyrosis UK
Hisfio UK
TrU5fEE5' REPORT (CONTINUED)
FOR THE YEAR EPIDED31 MAR012024
Awar•n•ss
Hlrtlocytosli UK 2024- Vlrtwl F(Yum on 18th January
Bulldlng on prevlous years, the fomiat of the 2024 programme for the Vlrtu81 Forum Included the ddlvery of
Abstracts, enabllng a platform for not only establlshed spedallsts but Introduced emer8ln8 new talent In the
fleld of H15ttocytlc dISorde￿ to a speclallsts audlence from the UK ind around the world.
HLH & Hyp•rlnfl•mm•tory Jyndrom•. Hojtr. Dr RId￿l T•tternill
AbrtrKt Pr•Mnt•rn
A B Verbeek
Elena Slenel
Danlel Gtro
Speakern
Dr. Blt• Sh•koory - Translatlonal Autolnfiammatory Dlseases Sect10￿ Natlonal Instltutes of Health Bethesda,
Maryland. US
A Mult1411s¢lplln•ry Approach to [DIa8n￿li ind Manapm•ntJ of E•rty/suJpert•d
H•MoPh•￿¢Ytlc Lwnphohlst1owJl￿M•¢r0Ph•￿• Acdvatlon Syndrom•
Dr. JeMlc• Man￿n - Consultant Rheumjtologht at UCLH, and Assoclate Honorary Professor at UCL
A practlral approach to th• m•na8•m•rt of p•tlents vAth HLH In th• UK
L•ns•th•M Cell Hljtlocytosls & other r•rnr dI￿rder5- Hojt Prof. Matthew Collln
Dr. C•rl Allen - Mllton and Allene Nlrken Ch•lr In Paedlatrfc Oncologyi Texa$ Chlldren's Hospltal Co-Dlrector,
HIS￿0CytoS75 Pro8ram Co-Dlrertor, Lyrnphoma Pro8rarn
Dlrector of Research, Global Haematol08￿OnCol06Y ￿edIatrIC Excellence IHOPEI
Professor, Department of Paedlatrlcs, Sectlon of HaematologwOncolo8y, Baylor Colle8e of Medlclne.
LCH2024: Pro8r•ii, Chaw •nd Opportunltl•J7
Plans for the futurn
Hlstlo UK remalns at the forefront In challenglng these dev4statln8 dlsorder5, we wlll contlnue b I￿lId on the
transfer of Infomiatlon and knowledge avallable natlonalty and Internatlonal throu8h our commlttee Structure
to parents, paiients and medlcal professlonals.

HISTIOCYTOSIS UK
HISTIO UK
TRusfEES' REpoirr ICOhmNUEDI
THE YEAR ENDED 31 MARCH 2024
st￿ctur￿ pv•rn•nce •nd rn•na8•m•nt
gonlsaiionalstructure
Hlstlocytosls UK Is a rewstered charlty. nurnber 1158789, and Is constltuted as a charltable Incorporated
or8an15atlon In En8lind and Wales.
The Charlty actlvely fundralses and seeks to ￿)nIlTrUe the charltable work deslred by the donor th￿Ugh the
careful stewardshlp of its exlstln8 resources.
At the annual Trustees, meetlngs, the Trurtees agree the broad strats8y and areas of actlvlty for the Charlty,
Includln8 conslderatton of 8rant makln& InvestmenL reseNes and rf5k management pollcles ind performance.
The day4Trday admlnlstrntlon of 8rants and the processln8 and handlln8 of appllc•tlons prfor to conslderatlon
by the Charfty Is dele8ated to the Executfve Dlrector.
The Charlty's Independent Sclentlflc Revlew Board conslder 811 applkatlons agalnst a8reed crlterkn prlor to
makln8 recommendatlon to the Charlty on fundlng grants. The SRB revlew all appllcatlons recelved In response
to calls for proposals.
Th• Chalr of t1￿ 5RB lor 202>2024
Professor Peter Beverley MBBS, DS4 Fmedscl
Vlc•<halr
Professor Matthew Collln. BM, Bch, Dphll. MRCP, FRCPath
The Trustees mlew on a re8ular basls both to recrult new Trustee{s) for thelr experfence, empathy and
knowledge of the charlty and to keep the skllls and composftion of the Trustee body and 5ucce551on plannln8
under revlew.
Move Into our new flnanclal year Trustees wlll retire at the end of thelr term of offlce wlth the Charlty. As
Iwaysi we wlll tak thts opportunlty to revlew our Governance structure and assess the benefits of utlllsln8 any
opportunltles that may be derlved from advtsory boards allowln8 U5 to more fulty sUPPOrt the Execut
Dlrector In forthcomlng projects and Inltlatfves and at the same tlme focus on our stren8th$.
Fundrqblnq Requlaiion
The Charlty Is re8lstered wlth the Fundratslng Re8ulator and Is In full compllance wlth Its requl*ments. The
Charlty adheres to the key prlnclple5 and behavlour5 In that the work of its fundrn151n8 wlll be Le8al. Open,
Honest and Respectful.
Rlsk manaqement
The Trustees have considered the major rlsks to whlch the charlty Is exposed and have revlewed those rfsks and
estsbllshed systems and procedures to manage those rf5ks.
The Trustees conslder varlablllty of Inve¥(ment returns.

Tro clo￿ to ••rvA Its ty •1 •Jr fjr th•lr ladmkyl
Irawn I¢￿
•ppmdb¥th••o•nlrfTnM
•ArA Kon

Hisnocyrosis UK
Hisno UK
srArEMEhrr OF TrusfEES' RESPONSIBIUTIES
FOR ThE YEAR ENDED 31 MARCH2024
The trustees ore responslble for preparln8 the Trustees, Report and the flnandal ststement$ In accordance wlth
appllcable law and Unlted Kln8dom Accountln8 Standard5 {Unlted Kln8dom Generally Accepted Accountln8
Practlce).
The law appllcable to charltles In England and Wales requlres the trustee5 to prepare financlal ststements for
each financlal year whlch Slve a true and falr vlew of the state of affalrs of the charlty and of the Incomlng
resource5 and appllcatlon of resources of the charlty for thit year.
In preparln& these flnandal statements, the trustees are requlred to:
- select suftable accountln8 pollcles and then apply them conslstentlyl
- observe the methods and prlndples In the Charltles SORP;
- mjke Jud8ements and estlmates that are reasonable and pNdent:
- stste whether appllcable accountfrq standards have been followed, subject to any materlal departures dlsclosed
and explalned In the flnjnclal 5titement5' and
prepare the Iln•nclal ststements on the 8oln8 concern basls unless It Is Inapproprlate to presume that the
thjrfty wlll contlnue In operatlon.
The trustees are responslble for keeplna sufflclent accountlng records that dlsclose wlth reasonable accuracy at
anytlme the flnancljl posltlon of the chorlty and enable them to ensure that the flnanclal statements comptywfth
the Charltles Act 2011, the Charlty (Accounts and Reports) Re8ulatlons 2(X)8 and the provlslons of the trust deed.
They are •150 responslble lor safe8u•rdln8 the assets of the charlty and hence for takln8 reasonable Steps for the
prevendon and detectlon of fraud and other Irregularltles.

Hisriocyrosis UK
HISTIO UK
INDEPENDENT EXAMINER'S REPORT
TO THE TRUSTEES OF Hisnocyrosis UK
I report to the trustees on my examlnallon of the flnanclal statements of Hlstlocytosls UK tthe charlty) for the
year ended 31 Marth 2024.
R•8ponslbllltlqi •nd b•Jls ol report
As the trustee5 of the charlty you are responslble for the preparntlon of the flnanclal statements In
accordance wtth the requlrements of the Charttles Act 2011 (the 2011 Act).
I report In respect of my examlnatlon of the charlty s flnanclal statsrnents carrled out under 5ectlon 145 of
the 2011 Act. In carryln8 Out my examlnatlon I have followed all the appllcable Dlrectlons glven by the Charlty
Commlsslon under sectlon 145(5)(b) of the 2011 Art.
Ind•p•nd•nt •xomlner* thtem•nt
Your attentlon Is drawn to the fact that the charlty has prepared flnanclal statsments In accordart• wfth
Accountln8 and Reportfn8 by Charftles preparln8 thelr accounts In accordance wlth the Flnandjl Rep(Ttln8
Standard appllcable In the UK and Republlc of Ireland IFRS 102) In preference to the Accountlng and
Reportlng by Charltles: Ststement of Recommended Practlce Issued on l Aprll 2005 whlch Ls referred to In the
extant re8ulatlons but has now been wlthdrawn.
l understsnd th•t thls has been done In order for fln•nclal statements to provlde a tru4 and falr vhw In
accordance wlth Generalty Accepted Accountln8 Pracilce effectlve for reportln8 perfods be8lnnln8 on or after
l Jinuary 2015.
I have completed my examlnatlon. I confirm that no matters have come to my attentlon In connectlon wtth
the ex?mlnatlon 8lvln8 me cause to belleve that In any materlal respect:
accountln8 records were not kept In respert of the Charfty w requlred by sectlon 130 of the 2011Act; or
the flnanclal statements do not accord wlth those records: or
the financlil statements do not comply wlth the appllcable requlrements concernlng the fomi and
content of accounts set out In the Charltles (Accounts and Report51 Regulatlons 2008 other than any
requlrement that the accounts 8fve a true and falr vlew whlch Is not a matter consldered as part of an
Independent examlnatlon.
I have no concerns and have come Jcross no other matters In connectfon wlth the exarnlnatlon to whth
attentlon should be drawn In thls rnport In order to enable a proper understsndln8 of the financlal
statements to be reached.
Chrlstopher McKenna ACA
TC Group
33 Bostan Road
Holbeach
Spaklln8
Lincolnshire
PE12 7LR
Datsd: .l.llk21.44.......

HISTiocYfosis UK
Hisllo UK
srATEMEhrr OF FINANCIAL p£nviTIES
INCWDING INCOME AND OtPENDrruRE ACCOUNT
FOR THE YEAR ENDED 31 MARCH2024
Unrertrkted Unrestrkted Restrlcted
fundl
funds
funds
2024
2023
2023
Totsl
2023
Donatlons and le8acles
Investments
121,963
4,864
141,526
1,704
9,￿0
151,426
L704
Tot•1 Incom•
126,827
143,230
9,9C
153,130
Ralslngfunds
1,281
1,073
1,073
Charltablè athttles
138,011
153,783
9,900
163,683
Totsl r•￿￿Tea1 •xp•nded
139,292
154,856
9,9C
164,756
N•t exp•ndltur• for th• y•ar/
N•t mov4m•nt In fun
(12,4651 (IL6261
IIL626)
Fund balances at l Aprll 2023
416,177
427,803
427,803
Fund hl•nceJ •t 31 March 2024
403,712
416,177
416,177
The statement of flnanclJl actlvftles Includes all 8alns and10sses recogntsed In the year.
All Income and expendlture derlve from contlnuln8 actMtle5.

HMI£> L
AfATJI AIAAa12024
at ￿nk irnl In ￿nd
417306
on•
1425Jj
414111J
4*177
401712
177
&177
nts wwe lpprnd bythi Ihtyw on.
MrAKf
•nnl4 Ch￿r
10-

HISTiocYfosis UK
Hisfio UK
NOTES TO THE FINANCIAL STATEMENIS
FOR THE YEAR ENIXD JI MARai 2024
Account1￿ pollclqs
1.1 Accountln8 ￿n￿ntIon
The flnanclal statements have been prepared In accordance wlth the charlty's 8overnlng document, the
Charltles Act 2011 and "Accountln8 and Reportln8 by Charltles: Statement of Recommended Practlce
appllcable to charltle5 preparlng thelr accounts In accordonce wlth the Flnanclal Reportln8 Stsndard
appllcable In the UK and Rewblk of Ireland (FRS 102) (effectlve l January 2019)" The charlty Is a Publlc
Benefit Errtlty as defined by FR5 102.
The charlty ha5 tsken advantage of the provlslon$ In the SORP for charttles applyln8 FRS 102 Update Bulletln
I not to prepare a Staternent of Cash Flow5.
The flnanclal statements have departed frorn the Charltle5 (Accounts and Reports) Re8ulatlons 21￿8 onty to
the extent requlred to provlde a true and falr vlew. Thls departure has Involved followln8 the StJtement of
Recommended Practlce for charftles applyln8 FRS 102 rnther than the verslon of the Ststement ol
Recommended Practlce whlch Is referred to In the Re8ulatlons but whkh has slnce been wlthdrawn.
The flnanclal ststements Jre prepared In sterlln8, whlch Is the functlonal currency of the charfty. Monetsry
•mounts In these flnandal statsments are rounded to the nearest £.
Thé financlll statsments have been prepared under the hlstorlcil cost conventlon, modlfled to Include the
revaluatlon of freehold propertles and to Indude Investment propertles and ￿rtaIn flnanclal InY<ruments at
falr value. The prlnclpal accountln8 polkles adopted •re set out below.
L2 6olryT conc4rn
At the tlme of approvlnB the flnanclal statements, the trustees hm a reasonable expectatlon that the
charlty has adequate resources to contlnue In aperatlonal exlstence for the foreseeable future. Thus the
trustees contfnue to adopt the 8oln8 concern basts of accountln8 In preparfn8 the flnanclal stotsments.
13 Ch•ritsble funds
Unrestrfcted funds are avallable for use at the dISc￿tiOn of the trustees In furtherance of thelr charltsble
obJeLtlves.
Restrlrted funds are subject to speclflc condltlons by donors as to how they rnay be used. The purFThes and
uses of the restrlcted funds are set out In the notes to the flnanclal st￿ementS.
Endowment fvnd5 are subject to speclflc condltlons by donors that the capftal must be malntsined ty the
charlty.
Income Is recognlsed when the charlty Is le8alty entltled to It after ary performance condlllons hwe been
m¢ the amounts can be measured rellably, and It Is probable that Income wlll be recAfved.
Cash donatlons are recognlsed on recelpt. Other donatlons are recognlsed once the chartty has been
notified of the donation, unless performance conditions requlre deferral of the amount. Incorne tax
recoverdble In relatSon to donations received under Gfft Ald or deeds of covenant Is recognised *( the time
of the donatlon.
11

HISTiocYfosis UK
HISTIO UK
NOTES TO THE FINANCIAL STATEMENTS {coNllNUED)
FOR THE YEAR ENDED 31 MARCH2024
Account1￿ polldej
(Contlnuqd)
Le8acles are reco8nlsed on recelpt or otherwlse If the charlty has been noffied of an Impendlng
dlstrlbutlon, the amountls known. and recelpt Is expected, If the amount Is not known, the legary b treated
45 a contln8ent asset.
LS Exp¢ndltur•
All expendfture Is recogntsed once there Is a legal or constructlve obll8atlon to that expendltur4 tt 15
probable settlement ts requlred and the amount can be measured rellabty. All costs are allocated to the
appllcJble expendlture headln8 that 088re8ate slmllar costs to that category. Where costs cannot be dlrectlv
attrlbuted to partlcular headln85 they have been allocated on • basls conslstent wlth the use of resources.
wlth central staff costs allocated on the bas15 of tlme spen¢ and depreclatlon charges allocated on the
portlon of the asset's use. Other 5UPPOrt costs are allocated based on the Spread of staff costs.
Ralslnifvnds
These are costs Incurred In attrnrtln8 voluntsry Income, the mana8ement of Investments and those hcurred
In trndln8 aCtlvltle5 that ralse funds.
Chorltable actfvl
Charftable expendfture comprtse5 those costs Incurred by the charlty In the dellvery of It5 acuvttes and
servlces for Its beneflclarles. It Includes both costs that can be allocated dlrectly to suth actlvltles ind those
Costs of an Indlrect nature necessary to support them.
1.6 Tan8lble fixed
Trn8lble flxed assets are Inlllpjlty measured at cost and subsequently measured at cost or Val￿tIOn, net of
depredatFon and any Impalrnient losses.
Depreclatlon Is reco8nlsed so as to wrfte off the cort or valuatlon of assets less thelr resldual values ¢)ver
thelr useful Ilves on the followln8 bases:
Office equlpment
33% reducln8 balanc•
The galn or loss arfslng on the dlsposal of an asset Is deternilned as the djfference between the sale
proceeds and the carryln8 value of the asset, and15 rew8nlsed In net Incomel(expendlture} forthe year.
1.7 Impalrmqnt off￿d asmts
At each reportln8 end date, the charlty revlews the carryln8 amounts of Its tan8lble assets to determlne
whether there 15 any Indlcallon that those assets have suffered an 1mpalrrnerrt1055. If any such Indlcatlon
exlsts, the recoverable amount of the asset Is estlmated In order to deternilne the extent of the Implrment
lou lff any).
Cmh Jnd cuh qqulv41ents
Cash and cash equivalent5 Include ￿5h In hand, deposlts held at call wlth banks, other shorkterm Ilquld
In4r5tment5 wtth 0rf8lnal maturftles of three rnonths or le55, and bank overdrnfts. Bank overdrafts are
shown wtthln bom)wlngs In C￿rrent Ilabllltle5.
12-

HISTiocYfosis UK
Hisfio UK
NOTES TO THE FINANaAL STATEMENTS ICONTINUED)
FOR THE YEAR ENDE031 MARCH 2024
Accountlnl polld
(ContInu￿}
1.9 Fln•ncl•l Instrum•nts
The charlty ha5 elected to appty the provlslons of Sertlon 11 '8Jslc Flnancljl Instrument5, and Sectlon 12
'Other Flnanclal Instruments Issues. of FRS 102 to all of tts flnanclal In¥(ruments.
Flnanclal Instruments are recogntsed In the charlty's balance she¥( when the charlty becomes party to the
contrartual provlsk>ns of the Instrument.
Flnanclal assets and Ilabllltles ire offset, wlth the net amounts presented In the flnanclal stjtsrnents, when
there Is a le8alty enforceable rlght to set off the recognlsed amounts and there b an Intentlon to Settle on
net basls or to reallse the asset and settle the Ilablllty slrnultsneouslv.
8aslcflnandal assets
Baslc financlil J55ets, whlch Include debtors and cash and bank balano$. are Inltl•lly measured
trnnsactlon prfce Indudlng transactlon costs and are subsequently carrfed at •mort15ed cost U51n8 the
effectlve Interest method unless the arrangement constftutes a financln8 transacllon. where the trarsactfon
Is measured at the present value of the future recelpts dlscounted at a market rate of Interest. Flrnndal
ai$•t$ classffled D5 Mcelvable wfthln one year are not amortl$ed.
8aslcflnonclolllobllllles
8•slc flnanclal Ilibllltfes, Indudlng credltors and bank loans are Inltlally reco8nlsed ot trnnsactlon prfce
uftless the arrangement constltutes a flnanclnB trnnsactlon, where the debt Instrument Is measured atthe
present value of the future payments dlscountsd at a rnarket rate of Intsre5t. Flnan¢lal Ilabllltfe5 cla55Med as
payable wlthln one year are not amortlsed.
Debt Instruments are subsequently carrled at amortlsed cost, U51n8 the effectlve Interest rate method.
Trade credltors are obll8atlons to pay for goods or servlces that have been acqulred In the ordlnary course of
operjtlons from suppllers. Amounts payable are classffied as current Ilabllltles Ir payment Is due wfthln one
year or less. If no( they are presented as non-current Ilabllltles. Trade credltors are recognlsed Inltlally at
transactlon prke and 5ub5equently measured at amortlsed cost usln8 the effectlve Interest method.
Derecognftlon offlnanclalllabllldes
Flnanclal Iljbllltles are derecognlsed when the charws contrattual obll8atlons explre or are dlscharyd or
cancelled.
LIO Employ•• b•n•fits
The cost of any unused hollday entltlement Is reco8nlsed In the perlod In whlch the employee'5 servlces are
recefved.
Termlnatlon benefits are reco8nlsed Immedlately as an expense when the char￿Y 15 demorlstrably
commltted to termlnate the employment of an employee or to provlde termlnatlon beneflts.
13-

HISTIOCYTOSIS UK
HISTIO UK
NOTES TO THE FINANCIAL sfAIEMENIS (coNllNUEDI
FOR THE YEAR EIVDED 31 MARCH 2024
Crltlcal account1￿ rftlm•tes and Ju*m•ri
In the appllcatlon of the charltvs accountln8 pollcles, the trustees are requlred to makn Judgements,
estlmates and as5umptlons about the carryln8 amount of assets and Ilabllltles that are not readlty apparent
from other sources. The estlmates and assoclated assumptlons are based on hlstorlcal experlence and other
factors th•t Jre consldered to be relevant. Actual results may dlfferfrom these estlmates.
The estlrnatss and undertylng assumptlons are mlewed on an on8oln8 basls. Revlslons to accountln8
estlrnates are recognlsed In the perfod In whlch the estlmate Is revlsed where the revtslon affects ￿lY thot
perlod, or In the perlod of the revlslon and future perlod5 where the revlslon affects both current and future
perlods.
Donatlons and l•8ad•i
Unrnstrkted Unrestrkted Restrlcted
lunds
funds
funds
Total
2024
2023
2023
2023
Donatlons and 8lfts
121,963
141,526
151,426
Don•tlanJ and glta
Donatlons
Glft ald tsx reclalrned
120,569
1394
141,401
125
151,301
125
12L963
141,526
9,9C
151,426
Invertments
UTrr•Jtrlrted Unre5trlrted
funds
funds
2024
2023
Interest recefvable
4,864
1,704
14-

HISTiocYf0515 UK
HISTIO UK
NOTES TO THE FINANCIAL sfATEMENTS IcoKfiNUEDI
FOR THE YEAR ENDED31 MARCH2024
R•liln8 funds
Unr•strfct•d Unrestrfcted
funds
funds
2024
2023
General fundra151n8 and event expenses
1,281
1,073
1,281
L073
Charftsble •rtlvhle8
Charftabh Charltabl•
Exp•ndlture Exp•ndltur•
2024
2023
Staff costs
Depreclatlon
Outreach costs
Travellln8
Insurance
Telephone
Computer expense$
Prlntln& posta8e, stallonery ind advertlsln8
Accountsncy fees
Bank charges
Interest payable
58.986
419
IL937
4,289
1,170
4,077
2,218
3,103
1.584
60
57,246
624
17,949
5,114
1,197
2,131
1,541
3.960
IA76
72
87,986
91,310
Grnnt fundln8 of actlvltles {see nots 7)
50,025
72.373
138,011
163.683
Anal￿1* by fund
Unrestrlcted funds
Restrlcted funds
138,011
153,783
9,9Crf)
15-

HISTIOCYTOSIS UK
HISTIO UK
NOTES TO THE FINANCIAL sfATEMEpifs (CONTINUEDI
FOR THE YEAR ENDED31 MARCH2Q24
Grants pAyabl•
Charftsbl• Charltable
Exp•ndltur• Expendtture
2024
2023
Research costs
50.025
72,373
50.025
72.373
8 Truits•J
None of the trustees (or any persons connected wlth them) recelved any remunerntlon or beneffts fm the
charlty durln8 the year.
Employ•
The evera8e rnonthly number of employee5 durlng the year wi5:
2024
Numb•r
2023
Numb•r
Employment costs
2024
2023
Wa8es and salarles
58,986
57,246
16-

Hisnocyrosls UK
Hisno UK
NOTES TO THE FINANCIAL sfATEMENTS (coNnNUED)
FOR THE YEAR EAIDED 31 MARCH 2024
10 Tan8lble fthd ass•ti
Ollk••qulpm•
At l Aprll 2023
5A90
At31 March 2024
5,45YI
D•pretl•tfon and Imp•lmi•nt
At l Aprll 2023
Depreclatlon char8ed In the ye•r
4,221
419
At 31 March 2024
C•ffyln8 •mount
At 31 March 2024
850
At 31 March 2023
1,269
11 D•btor4
2024
2023
Amounts falllni du• wlthln one ye•r:
Prepayments and accrued Income
941
855
12 Credltsrs: amounts f•llln8 due wlthln one y￿r
2024
2023
Other taxatlon and soclal securlty
Accru•15 and deferred Income
1,950
1,512
I￿13
3A62
3,253
17-

HISTiocYfosis UK
Hisllo UK
NOTES TO THE FINANaAL sfATEMENTS (coNnNUED)
FOR THE YEAR EPIDED 32 MAR012Q24
13 Ana￿1$ of not amets b•tw•en lund•
Unr•strict•d Unrestrlcted Restrlcted
fvnds
funds
funds
2024
2023
2023
Totsi
2023
Fund balances Jt 31 March 2024 are represented
Tar￿ble assets
Current assets1{Ilabllltlesl
850
402.862
1.269
414,908
1,269
414.908
403,712
416,177
416.177
14 R•knted prty tr•nM¢tl¢)ni
Tharn were no dlsclomblo related party transactlons durln8 the ￿•r (2023- none).
18-

## **Document Activity Report** 

## **Document Sent** 

Mon, 17 Jun 2024 08:25:00 GMT 

## **Document Activity History** 

Document history shows most recent activity first 

## **Date** 

## **Activity** 

You can verify that this is a genuine Portal document by uploading it to the following secure web page: 

**http://tcgroup2.accountantspace.co.uk/messages/VerifyDocument**